BLFS,LAB Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.02
Percentage change 0.09	%

Peers: CRSP CYRX NTLA BIO BMRN FATE NARI ASTE VIVS KPTI

| Held by: IJR VTI IWM VXF IJT SPSM IWO VTWO SLYG SCHA

Index	RUT	P/E	-	EPS (ttm)	-0.04	Insider Own	4.07%	Shs Outstand	47.55M	Perf Week	-8.34%
Market Cap	1.03B	Forward P/E	250.58	EPS next Y	0.09	Insider Trans	-37.67%	Shs Float	45.63M	Perf Month	-5.14%
Income	-1.51M	PEG	-	EPS next Q	-0.03	Inst Own	99.22%	Short Float	10.26%	Perf Quarter	-14.60%
Sales	105.55M	P/S	9.81	EPS this Y	67.53%	Inst Trans	2.50%	Short Ratio	8.00	Perf Half Y	-18.50%
Book/sh	7.42	P/B	2.93	EPS next Y	206.98%	ROA	-2.84%	Short Interest	4.68M	Perf Year	7.72%
Cash/sh	1.86	P/C	11.68	EPS next 5Y	-	ROE	-3.29%	52W Range	18.70 - 29.55	Perf YTD	-16.18%
Dividend Est.	-	P/FCF	89.30	EPS past 5Y	-55.83%	ROIC	-0.41%	52W High	-26.35%	Beta	1.82
Dividend TTM	-	Quick Ratio	3.74	Sales past 5Y	24.62%	Gross Margin	54.95%	52W Low	16.36%	ATR (14)	1.19
Dividend Ex-Date	-	Current Ratio	4.73	EPS Y/Y TTM	97.46%	Oper. Margin	-7.28%	RSI (14)	44.45	Volatility	2.78% 3.37%
Employees	159	Debt/Eq	0.08	Sales Y/Y TTM	-23.12%	Profit Margin	-1.44%	Recom	1.00	Target Price	31.22
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	95.78%	Payout	-	Rel Volume	1.01	Prev Close	21.74
Sales Surprise	7.74%	EPS Surprise	79.42%	Sales Q/Q	-24.54%	Earnings	May 08 AMC	Avg Volume	585.55K	Price	21.76
SMA20	-2.57%	SMA50	-4.18%	SMA200	-11.80%	Trades		Volume	131,596	Change	0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-24	Initiated	H.C. Wainwright	Buy	$29
Apr-04-24	Initiated	Jefferies	Buy	$22
Jul-11-23	Initiated	Craig Hallum	Buy	$29
Apr-25-22	Upgrade	Oppenheimer	Perform → Outperform	$28
Oct-19-21	Initiated	B. Riley Securities	Buy	$61
Oct-15-21	Resumed	Cowen	Outperform	$64
May-14-21	Downgrade	The Benchmark Company	Buy → Hold
Mar-23-21	Upgrade	The Benchmark Company	Hold → Buy	$54
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$40
Sep-22-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-18-20	Initiated	Cowen	Outperform	$33
Aug-11-20	Downgrade	The Benchmark Company	Buy → Hold
Jul-08-20	Reiterated	Maxim Group	Buy	$18 → $26
Feb-24-20	Initiated	Lake Street	Buy	$25
Feb-19-20	Initiated	The Benchmark Company	Buy	$24
Feb-06-20	Resumed	B. Riley FBR	Buy	$27
Jan-08-20	Initiated	Stephens	Overweight	$23
Nov-21-19	Initiated	Oppenheimer	Outperform	$22
Jul-22-19	Initiated	H.C. Wainwright	Buy	$23
Nov-10-17	Reiterated	Maxim Group	Buy	$7 → $8

Show Previous Ratings

Jun-05-25 09:55AM	How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72% (Zacks)
May-28-25 02:16PM	H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock (Insider Monkey)
May-21-25 01:22PM	EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint (Zacks)
05:26AM	Merit Medical acquires haemostatic device manufacturer Biolife for $120m (Medical Device Network)
May-14-25 08:03AM	BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025 (PR Newswire)
09:55AM	Loading…
May-13-25 09:55AM	Can BioLife Solutions (BLFS) Climb 30.68% to Reach the Level Wall Street Analysts Expect? (Zacks)
May-09-25 03:38AM	BioLife Solutions Inc (BLFS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-08-25 05:25PM	BioLife Solutions, Inc. (BLFS) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:32PM	BioLife Solutions Updates Earnings Call Information (PR Newswire)
04:03PM	BioLife Solutions Reports First Quarter 2025 Financial Results (PR Newswire)
May-07-25 05:45PM	Green Thumb Industries Inc. (GTBIF) Q1 Earnings and Revenues Miss Estimates (Zacks)
05:20PM	BioLife Solutions Q1 2025 Earnings Preview (Seeking Alpha)
10:23AM	What To Expect From BioLife Solutions Inc (BLFS) Q1 2025 Earnings (GuruFocus.com)
Apr-30-25 08:03AM	BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 (PR Newswire)
Apr-23-25 05:15PM	ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates (Zacks) +11.24%
05:17AM	Loading…
Apr-10-25 05:17AM	Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? (Zacks) -7.90%
Apr-07-25 08:03AM	BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company (PR Newswire) +5.08%
Apr-06-25 09:00AM	BioLife Solutions Stock: Back On Track, But Still Expensive (Seeking Alpha)
04:43AM	BioLife Solutions: A Steady Stock Lined Up For Success In A Booming Industry (Seeking Alpha)
Mar-24-25 07:27AM	5 Low-Leverage Stocks to Buy Amid Trump's Tariff Woes (Zacks) +5.68%
Mar-18-25 08:30AM	BioLife Solutions Appoints Cathy Coste as Director and Audit Committee Chair (PR Newswire)
Mar-04-25 02:00AM	BioLife Solutions Inc (BLFS) Q4 2024 Earnings Call Highlights: Strong Margin Growth and ... (GuruFocus.com)
Mar-03-25 11:43PM	Q4 2024 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
08:10AM	BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Feb-28-25 07:10AM	What To Expect From BioLife Solutions Inc (BLFS) Q4 2024 Earnings (GuruFocus.com)
Feb-20-25 04:03PM	BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025 (PR Newswire)
Jan-29-25 09:15AM	BioLife Solutions, Inc. (BLFS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jan-24-25 09:40AM	Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-22-25 08:50AM	BioLife Solutions (BLFS) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
08:30AM	Loading…
Jan-13-25 08:30AM	BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations (PR Newswire)
Dec-16-24 08:11AM	BioLife Solutions Appoints Tony J. Hunt to its Board of Directors (PR Newswire)
Nov-14-24 04:05PM	BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary (PR Newswire) -10.20%
Nov-13-24 02:16AM	BioLife Solutions Inc (BLFS) Q3 2024 Earnings Call Highlights: Strategic Divestitures and ... (GuruFocus.com) -9.02%
Nov-12-24 05:45PM	BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	BioLife Solutions Reports Third Quarter 2024 Financial Results (PR Newswire)
08:05AM	BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary (PR Newswire)
Nov-11-24 07:11AM	What To Expect From BioLife Solutions Inc (BLFS) Q3 2024 Earnings (GuruFocus.com)
Oct-31-24 04:03PM	BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024 (PR Newswire)
Oct-21-24 09:40AM	Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? (Zacks)
Oct-09-24 05:55PM	BioLife Solutions Inc (BLFS) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -5.13%
Oct-07-24 08:50AM	Here's Why Momentum in BioLife Solutions (BLFS) Should Keep going (Zacks)
Sep-30-24 09:41AM	Disney upgraded, JPMorgan downgraded: Wall Street's top analyst calls (The Fly)
Sep-17-24 09:40AM	Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? (Zacks) -7.89%
Aug-19-24 02:05AM	BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2 (Insider Monkey)
Aug-08-24 09:58PM	BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +11.04%
05:45PM	BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports Second Quarter 2024 Financial Results (PR Newswire)
Aug-06-24 03:56PM	Is BioLife Solutions, Inc. (BLFS) the Best Organ Transplant and Diagnosis Stock to Buy Now? (Insider Monkey)
Jul-25-24 04:03PM	BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 (PR Newswire)
Jul-12-24 08:50AM	What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing' (Zacks)
Jun-18-24 07:00PM	Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com)
May-31-24 11:17AM	BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase (Zacks)
May-29-24 08:04AM	BioLife Solutions Introduces the CellSeal CryoCase at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver (PR Newswire)
May-18-24 02:34AM	Insider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... (GuruFocus.com)
May-13-24 07:08AM	Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target (MT Newswires) +5.73%
May-10-24 12:37PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript (Insider Monkey) +8.50%
May-09-24 10:57PM	BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports First Quarter 2024 Financial Results (PR Newswire)
May-02-24 10:01AM	BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-24 04:12PM	BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 (PR Newswire)
Apr-18-24 11:00AM	Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... (GuruFocus.com)
08:05AM	BioLife Solutions Announces the Divestiture of its Stirling Freezer Business (PR Newswire)
Mar-27-24 04:37PM	Corporate Insiders Are Selling These 10 Small-Cap Stocks (Insider Monkey)
Mar-14-24 02:15AM	Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com)
Mar-13-24 01:50AM	Insider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com) +5.77%
Mar-04-24 08:03AM	BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences (PR Newswire)
Mar-02-24 08:16AM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:02AM	Q4 2023 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents) +6.33%
Feb-29-24 04:03PM	BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-20-24 08:03AM	BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 (PR Newswire)
Jan-08-24 08:15AM	BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue (PR Newswire) +10.16%
Nov-16-23 02:54AM	BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales Cycles (Insider Monkey)
Nov-10-23 02:33PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:04PM	BioLife Solutions Reports Third Quarter 2023 Financial Results (PR Newswire)
Nov-02-23 04:03PM	BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023 (PR Newswire) +8.02%
12:27AM	Former CEO Michael Rice Sells 72,603 Shares of BioLife Solutions Inc (GuruFocus.com)
Oct-19-23 05:04PM	BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023 (PR Newswire) -8.85%
Oct-09-23 04:24AM	New Strong Sell Stocks for October 9th (Zacks)
Sep-13-23 07:47AM	New Strong Sell Stocks for September 13th (Zacks)
Aug-11-23 04:06PM	Why Shares of BioLife Solutions Plummeted This Week (Motley Fool)
06:05AM	Some BioLife Solutions, Inc. (NASDAQ:BLFS) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Aug-09-23 01:38PM	Why Shares of BioLife Solutions Are Slumping on Wednesday (Motley Fool) -28.71%
Aug-08-23 06:30PM	BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business (PR Newswire)
Jul-27-23 04:03PM	BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023 (PR Newswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jun-21-23 08:00PM	BLFS: What does Argus have to say about BLFS? (Argus Research)
Jun-14-23 08:03AM	BioLife Solutions Receives College of American Pathologists CAP-BAP Accreditation for All SciSafe® U.S. Biostorage Facilities (PR Newswire)
Jun-06-23 08:03AM	BioLife Solutions Launches the IntelliRate i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer (PR Newswire)
May-12-23 07:45AM	We Think BioLife Solutions (NASDAQ:BLFS) Can Easily Afford To Drive Business Growth (Simply Wall St.)
May-11-23 07:34AM	Q1 2023 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 05:35PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports First Quarter 2023 Financial Results (PR Newswire)
May-02-23 04:03PM	BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023 (PR Newswire) -5.03%
Apr-26-23 08:00PM	BLFS: Lowering target price to $14.00 (Argus Research)
Mar-20-23 10:46PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript (Insider Monkey) +6.21%
Mar-17-23 08:39AM	Q4 2022 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents) +7.71%
Mar-16-23 04:03PM	BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results (PR Newswire) -6.98%

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SARAH AEBERSOLD	Officer	Jun 16 '25	Proposed Sale	22.03	711	15,663		Jun 16 04:22 PM
Casdin Partners Master Fund, L	10% Owner	Jun 10 '25	Sale	23.80	1,000,000	23,800,000	7,707,165	Jun 12 08:27 PM
Berard Todd	Chief Marketing Officer	Jun 10 '25	Sale	23.70	362	8,579	134,922	Jun 12 05:24 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jun 10 '25	Sale	23.70	637	15,097	353,118	Jun 12 05:24 PM
Wichterman Troy	Chief Financial Officer	Jun 10 '25	Sale	23.70	1,042	24,695	186,685	Jun 12 05:24 PM
Werner Sean	Chief Technology Officer	Jun 10 '25	Sale	23.70	65	1,540	27,610	Jun 12 05:24 PM
Aebersold Sarah	Chief Human Resources Officer	Jun 10 '25	Sale	23.70	235	5,570	79,432	Jun 12 05:23 PM
Foster Karen A.	Chief Quality and Operations	Jun 10 '25	Sale	23.70	320	7,584	194,996	Jun 12 05:23 PM
Casdin Partners Master Fund, L	10% Owner	Jun 10 '25	Proposed Sale	23.91	1,000,000	23,910,000		Jun 10 09:32 PM
Foster Karen A.	Chief Quality and Operations	May 28 '25	Sale	22.46	251	5,637	195,316	May 30 06:09 PM
Aebersold Sarah	Chief Human Resources Officer	May 28 '25	Sale	22.46	217	4,874	79,667	May 30 06:09 PM
Berard Todd	Chief Marketing Officer	May 28 '25	Sale	22.46	348	7,816	135,284	May 30 06:06 PM
Mathew Aby J.	EVP & Chief Scientific Officer	May 28 '25	Sale	22.46	521	11,702	308,486	May 30 06:04 PM
Werner Sean	Chief Technology Officer	May 28 '25	Sale	22.46	109	2,448	27,675	May 30 05:57 PM
Wichterman Troy	Chief Financial Officer	May 28 '25	Sale	22.46	583	13,094	187,727	May 30 05:54 PM
Wichterman Troy	Chief Financial Officer	Apr 09 '25	Sale	20.11	932	18,743	188,310	Apr 11 05:49 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Apr 09 '25	Sale	20.11	569	11,443	309,007	Apr 11 05:49 PM
Aebersold Sarah	Chief Human Resources Officer	Apr 09 '25	Sale	20.11	210	4,223	79,884	Apr 11 05:49 PM
Berard Todd	Chief Marketing Officer	Apr 09 '25	Sale	20.11	324	6,516	135,632	Apr 11 05:49 PM
Foster Karen A.	Chief Quality and Operations	Apr 09 '25	Sale	20.11	286	5,751	195,567	Apr 11 05:49 PM
Aebersold Sarah	Chief Human Resources Officer	Apr 01 '25	Sale	22.66	5,771	130,771	80,094	Apr 03 05:48 PM
Berard Todd	Chief Marketing Officer	Apr 01 '25	Sale	22.66	8,902	201,719	135,956	Apr 03 05:48 PM
Wichterman Troy	Chief Financial Officer	Apr 01 '25	Sale	22.66	25,687	582,067	189,242	Apr 03 05:48 PM
Foster Karen A.	Chief Quality and Operations	Apr 01 '25	Sale	22.66	7,869	178,312	195,853	Apr 03 05:48 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Apr 01 '25	Sale	22.66	10,589	239,947	309,576	Apr 03 05:48 PM
DuRoss Amy	Director	Mar 14 '25	Sale	24.96	5,632	140,575	23,811	Mar 20 07:09 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 14 '25	Sale	24.96	5,632	140,575	45,860	Mar 18 05:59 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 17 '25	Sale	25.44	2,695	68,561	43,165	Mar 18 05:59 PM
SARAH AEBERSOLD	Officer	Mar 17 '25	Proposed Sale	25.00	2,695	67,375		Mar 17 04:27 PM
AMY DUROSS	Director	Mar 14 '25	Proposed Sale	25.06	5,632	141,138		Mar 14 04:25 PM
Berard Todd	Chief Marketing Officer	Mar 11 '25	Sale	25.00	1,577	39,425	104,961	Mar 13 05:26 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 12 '25	Sale	26.34	7,324	192,914	51,492	Mar 13 05:26 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 11 '25	Sale	25.00	1,091	27,275	58,816	Mar 13 05:26 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Mar 11 '25	Sale	25.00	1,597	39,925	260,601	Mar 13 05:26 PM
Foster Karen A.	Chief Quality and Operations	Mar 11 '25	Sale	25.00	1,331	33,275	154,912	Mar 13 05:26 PM
Wichterman Troy	Chief Financial Officer	Mar 11 '25	Sale	25.00	4,151	103,775	116,809	Mar 13 05:25 PM
SARAH AEBERSOLD	Officer	Mar 12 '25	Proposed Sale	26.62	7,324	194,965		Mar 12 04:23 PM
Werner Sean	Chief Technology Officer	Mar 03 '25	Sale	25.46	136	3,463	4,953	Mar 05 05:14 PM
Werner Sean	Chief Technology Officer	Mar 04 '25	Sale	24.03	88	2,115	4,865	Mar 05 05:14 PM
Foster Karen A.	Chief Quality and Operations	Mar 03 '25	Sale	25.46	324	8,249	156,243	Mar 05 05:13 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Mar 03 '25	Sale	25.46	425	10,820	262,198	Mar 05 05:13 PM
Wichterman Troy	Chief Financial Officer	Mar 03 '25	Sale	25.46	660	16,804	120,960	Mar 05 05:13 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 03 '25	Sale	25.46	284	7,231	59,907	Mar 05 05:13 PM
Berard Todd	Chief Marketing Officer	Mar 03 '25	Sale	25.46	424	10,795	106,538	Mar 05 05:13 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Feb 12 '25	Sale	26.54	92	2,442	262,623	Feb 14 05:47 PM
Wichterman Troy	Chief Financial Officer	Feb 12 '25	Sale	26.54	159	4,220	121,620	Feb 14 05:47 PM
Foster Karen A.	Chief Quality and Operations	Feb 12 '25	Sale	26.54	78	2,070	156,567	Feb 14 05:46 PM
Berard Todd	Chief Marketing Officer	Feb 12 '25	Sale	26.54	102	2,707	106,962	Feb 14 05:46 PM
Aebersold Sarah	Chief Human Resources Officer	Feb 12 '25	Sale	26.54	53	1,407	60,191	Feb 14 05:46 PM
Aebersold Sarah	Chief Human Resources Officer	Jan 06 '25	Sale	27.02	240	6,485	60,244	Jan 08 07:11 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jan 06 '25	Sale	27.02	404	10,916	262,715	Jan 08 07:11 PM
Berard Todd	Chief Marketing Officer	Jan 06 '25	Sale	27.02	343	9,268	107,064	Jan 08 07:10 PM
DE GREEF RODERICK	President and CEO	Oct 31 '24	Sale	23.43	46,896	1,098,773	414,958	Jan 08 07:10 PM
Foster Karen A.	Chief Quality and Operations	Jan 06 '25	Sale	27.02	328	8,863	156,645	Jan 08 07:10 PM
Wichterman Troy	Chief Financial Officer	Jan 06 '25	Sale	27.02	987	26,669	121,779	Jan 08 07:10 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Dec 17 '24	Sale	27.16	13,196	358,403	263,119	Dec 19 05:19 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Dec 16 '24	Sale	27.33	7,604	207,817	276,315	Dec 19 05:19 PM
Wichterman Troy	Chief Financial Officer	Nov 26 '24	Sale	27.20	581	15,803	122,766	Nov 29 05:30 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 26 '24	Sale	27.20	523	14,226	283,919	Nov 29 05:30 PM
Berard Todd	Chief Marketing Officer	Nov 26 '24	Sale	27.20	349	9,493	107,407	Nov 29 05:29 PM
Aebersold Sarah	Chief Human Resources Officer	Nov 26 '24	Sale	27.20	216	5,875	60,484	Nov 29 05:29 PM
Foster Karen A.	Chief Quality and Operations	Nov 26 '24	Sale	27.20	252	6,854	156,973	Nov 29 05:29 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 15 '24	Option Exercise	2.06	10,000	20,600	327,046	Nov 19 05:32 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 15 '24	Sale	21.17	25,000	529,150	302,046	Nov 19 05:32 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 18 '24	Sale	20.05	17,604	352,960	284,442	Nov 19 05:32 PM
Berard Todd	Chief Marketing Officer	Nov 12 '24	Sale	26.34	91	2,397	107,756	Nov 14 06:38 PM
Foster Karen A.	Chief Quality and Operations	Nov 12 '24	Sale	26.34	66	1,738	157,225	Nov 14 06:38 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 12 '24	Sale	26.34	123	3,240	317,046	Nov 14 06:37 PM
Wichterman Troy	Chief Financial Officer	Nov 12 '24	Sale	26.19	147	3,850	123,347	Nov 14 06:37 PM
Aebersold Sarah	Chief Human Resources Officer	Oct 30 '24	Sale	23.15	203	4,699	60,700	Nov 01 07:02 PM
Berard Todd	Chief Marketing Officer	Oct 30 '24	Sale	23.15	311	7,200	107,847	Nov 01 07:01 PM
Foster Karen A.	Chief Quality and Operations	Oct 30 '24	Sale	23.15	277	6,413	157,291	Nov 01 07:01 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 30 '24	Sale	23.15	547	12,663	317,169	Nov 01 07:01 PM
Wichterman Troy	Chief Financial Officer	Oct 30 '24	Sale	23.15	894	20,696	123,494	Nov 01 07:01 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 15 '24	Option Exercise	2.06	10,000	20,600	327,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 16 '24	Option Exercise	2.06	10,000	20,600	327,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 15 '24	Sale	23.28	10,000	232,800	317,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 16 '24	Sale	23.17	10,000	231,700	317,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 18 '24	Option Exercise	2.06	10,000	20,600	327,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 19 '24	Option Exercise	2.06	10,000	20,600	327,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 19 '24	Sale	25.47	10,000	254,700	317,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 18 '24	Sale	23.90	10,000	239,000	317,716	Sep 20 05:36 PM
Foster Karen A.	Chief Quality and Operations	Sep 16 '24	Sale	25.12	267	6,707	157,568	Sep 18 05:45 PM
Foster Karen A.	Chief Quality and Operations	Jul 18 '24	Sale	22.50	240	5,400	157,931	Sep 18 05:45 PM
Foster Karen A.	Chief Quality and Operations	Aug 21 '24	Sale	25.61	96	2,459	157,835	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Sep 16 '24	Sale	25.12	367	9,219	108,158	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Jul 11 '24	Sale	20.54	287	5,895	108,607	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Aug 21 '24	Sale	25.61	82	2,100	108,525	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 16 '24	Sale	25.12	343	8,616	317,716	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jul 11 '24	Sale	20.54	313	6,429	318,170	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Aug 21 '24	Sale	25.61	111	2,843	318,059	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Jul 19 '24	Sale	21.01	300	6,303	61,196	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Sep 16 '24	Sale	25.12	229	5,752	60,903	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Jul 11 '24	Sale	20.54	187	3,841	61,496	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Aug 21 '24	Sale	25.61	64	1,639	61,132	Sep 18 05:45 PM
Wichterman Troy	Chief Financial Officer	Jul 11 '24	Sale	20.54	828	17,007	125,141	Sep 18 05:44 PM
Wichterman Troy	Chief Financial Officer	Sep 16 '24	Sale	25.12	611	15,348	124,388	Sep 18 05:44 PM
Wichterman Troy	Chief Financial Officer	Aug 21 '24	Sale	25.61	142	3,637	124,999	Sep 18 05:44 PM
Richardson Garrie	Chief Revenue Officer	Sep 16 '24	Sale	25.12	3,070	77,118	114,773	Sep 18 05:44 PM
ABY J MATHEW	Officer	Sep 18 '24	Proposed Sale	23.45	103,404	2,424,824		Sep 18 04:37 PM

Dollar change +0.06
Percentage change 5.88	%

LAB Standard BioTools Inc daily Stock Chart

Peers: TMO DHR A ILMN BIO QGEN TECH TWST PACB DNA

| Held by: VTI IWM VXF ARKG IBB IWN VTWO SCHA VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-0.36	Insider Own	3.66%	Shs Outstand	379.09M	Perf Week	0.00%
Market Cap	410.21M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	52.12%	Shs Float	365.93M	Perf Month	2.86%
Income	-132.76M	PEG	-	EPS next Q	-0.07	Inst Own	72.28%	Short Float	4.66%	Perf Quarter	-8.47%
Sales	169.69M	P/S	2.42	EPS this Y	55.77%	Inst Trans	2.42%	Short Ratio	13.46	Perf Half Y	-43.46%
Book/sh	1.20	P/B	0.90	EPS next Y	36.23%	ROA	-19.56%	Short Interest	17.04M	Perf Year	-49.77%
Cash/sh	0.68	P/C	1.59	EPS next 5Y	66.44%	ROE	-25.73%	52W Range	0.92 - 2.41	Perf YTD	-38.29%
Dividend Est.	-	P/FCF	-	EPS past 5Y	11.61%	ROIC	-27.67%	52W High	-55.19%	Beta	1.50
Dividend TTM	-	Quick Ratio	5.37	Sales past 5Y	8.27%	Gross Margin	45.96%	52W Low	17.39%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	6.12	EPS Y/Y TTM	64.34%	Oper. Margin	-74.44%	RSI (14)	51.18	Volatility	5.11% 5.10%
Employees	818	Debt/Eq	0.07	Sales Y/Y TTM	33.86%	Profit Margin	-78.24%	Recom	1.67	Target Price	2.38
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	74.12%	Payout	-	Rel Volume	0.49	Prev Close	1.02
Sales Surprise	1.73%	EPS Surprise	-27.27%	Sales Q/Q	-10.42%	Earnings	May 06 AMC	Avg Volume	1.27M	Price	1.08
SMA20	3.35%	SMA50	-1.45%	SMA200	-29.27%	Trades		Volume	138,446	Change	5.88%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-16-24	Initiated	TD Cowen	Buy	$3.50
Apr-04-24	Initiated	Jefferies	Buy	$3.25
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight	$4

May-30-25 07:00AM	Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series (GlobeNewswire)
May-09-25 05:00PM	Labrador Gold Announces Resignation of Director Kai Hoffmann (GlobeNewswire) +8.41%
May-07-25 08:26AM	Q1 2025 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
03:20AM	Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-06-25 05:15PM	Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.83%
04:01PM	Loading…
04:01PM	Standard BioTools Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-05-25 10:10AM	Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-24-25 07:00AM	Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 (GlobeNewswire)
Apr-22-25 04:05PM	Sight Sciences Appoints Gary Burbach to its Board of Directors (GlobeNewswire) +6.72%
07:00AM	Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 (GlobeNewswire)
Feb-27-25 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire) -10.68%
07:09AM	Q4 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
02:22AM	Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Feb-26-25 06:52PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance) -7.14%
04:01PM	Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
10:54AM	Loading…
Feb-25-25 10:54AM	Standard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.26%
Feb-12-25 07:00AM	Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 (GlobeNewswire)
Jan-13-25 07:00AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue (GlobeNewswire) +26.38%
Jan-08-25 07:00AM	Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine (GlobeNewswire)
Dec-19-24 08:00AM	Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-07-24 08:00AM	Standard BioTools Appoints Alex Kim as Chief Financial Officer (GlobeNewswire)
Oct-31-24 11:00AM	Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... (GuruFocus.com)
08:01AM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-30-24 05:20PM	Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.43%
04:15PM	Standard BioTools: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-21-24 09:03PM	Millennium Management LLC Acquires Shares in Standard BioTools Inc (GuruFocus.com)
Oct-16-24 08:00AM	Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire)
Oct-03-24 04:56AM	Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5? (Insider Monkey)
Sep-24-24 08:00AM	Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan 11K Platform (GlobeNewswire) +5.35%
08:00AM	Loading…
Sep-18-24 08:00AM	Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH) (GlobeNewswire)
Aug-26-24 08:00AM	Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-23-24 06:03PM	Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors (Barrons.com) +9.74%
Aug-06-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-01-24 09:14AM	Q2 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -36.61%
Jul-31-24 09:57PM	LAB Stock Earnings: Standard BioTools Reported Results for Q2 2024 (InvestorPlace)
05:40PM	Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:36PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Standard BioTools Announces Senior Leadership Changes (GlobeNewswire)
04:01PM	Standard BioTools Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-17-24 08:01AM	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire)
May-28-24 04:01PM	Standard BioTools Purchases the Carterra LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers (GlobeNewswire)
May-22-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-20-24 08:00AM	Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-13-24 10:45AM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:59PM	LAB Stock Earnings: Standard BioTools Reported Results for Q1 2024 (InvestorPlace) -5.49% +7.59%
04:33PM	Standard BioTools: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 11:27AM	Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction (MT Newswires)
08:01AM	Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth (GlobeNewswire)
08:00AM	Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-08-24 08:00AM	Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging (GlobeNewswire) +5.11%
Apr-03-24 04:01PM	Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research (GlobeNewswire)
Mar-18-24 08:12AM	Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock (GlobeNewswire)
Mar-05-24 08:27AM	Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 06:29AM	Q4 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -5.06%
Feb-28-24 04:41PM	Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... (GuruFocus.com)
04:16PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 08:00AM	Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing (GlobeNewswire)
Feb-22-24 04:05PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-14-24 08:30AM	Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Feb-07-24 08:30AM	Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine (GlobeNewswire)
Jan-08-24 08:30AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue (GlobeNewswire) +13.37%
Jan-05-24 08:46AM	Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools (GlobeNewswire)
Jan-04-24 10:23PM	Standard BioTools Stockholders Approve Merger with SomaLogic (GlobeNewswire) -5.39%
09:44PM	SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting (PR Newswire)
Dec-29-23 05:04PM	Glass Lewis Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-28-23 04:16PM	Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools (PR Newswire) +5.45%
Dec-26-23 03:59PM	SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure (PR Newswire) +7.54%
Dec-22-23 06:57PM	ISS Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-21-23 08:00AM	SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools (GlobeNewswire)
Dec-20-23 09:00AM	Skye Fund III Issues Letter Regarding Opposition to SomaLogic's Proposed Merger with Standard BioTools (GlobeNewswire) -8.10%
Dec-17-23 03:37PM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-12-23 04:32PM	SomaLogic Shareholder Madryn Opposes Standard BioTools Merger (Bloomberg)
Dec-11-23 10:37AM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-06-23 11:18AM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-04-23 08:00AM	Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger (GlobeNewswire)
Nov-09-23 05:54AM	Q3 2023 Somalogic Inc Earnings Call (Thomson Reuters StreetEvents) +6.84%
Nov-08-23 12:47PM	Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:52AM	Q3 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 04:23PM	Standard BioTools: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results (GlobeNewswire)
Nov-02-23 08:30AM	Standard BioTools to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-25-23 08:30AM	Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire) -10.50%
Oct-10-23 10:22AM	Moore Kuehn Encourages VERY, PNT, LAB, and LVOX Investors to Contact Law Firm (GlobeNewswire)
Oct-05-23 02:42PM	Moore Kuehn Encourages APRN, FRGI, LAB, and CPRI Investors to Contact Law Firm (PR Newswire)
Oct-04-23 06:49PM	Why SomaLogic Stock Dived by 10% on Wednesday (Motley Fool) -22.22%
08:52AM	Standard BioTools to Combine with SomaLogic in $1 Billion Merger (Bloomberg)
08:00AM	Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools (GlobeNewswire)
Aug-09-23 09:06AM	Q2 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) +7.56%
Aug-08-23 05:36PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Standard BioTools Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-25-23 04:05PM	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-13-23 07:33AM	Strong week for Standard BioTools (NASDAQ:LAB) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.)
Jun-14-23 07:30AM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-13-23 01:30PM	With 45% ownership, Standard BioTools Inc. (NASDAQ:LAB) has piqued the interest of institutional investors (Simply Wall St.)
May-25-23 04:05PM	Standard BioTools to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-24-23 07:11AM	With Standard BioTools Up 29%, Insider Buyers Count Their Returns \ (Simply Wall St.)

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kim Hanjoon Alex	Chief Financial Officer	May 23 '25	Sale	0.94	1,428	1,344	930,286	May 28 05:54 PM
Mackay Sean	SVP & Chief Business Officer	May 23 '25	Sale	0.94	13,217	12,437	843,076	May 28 05:52 PM
Egholm Michael	President & CEO	May 23 '25	Sale	0.94	5,473	5,150	2,741,191	May 28 05:44 PM
Kim Hanjoon Alex	Chief Financial Officer	May 22 '25	Sale	1.00	1,355	1,358	931,714	May 27 08:33 PM
Egholm Michael	President & CEO	May 22 '25	Sale	1.00	5,116	5,126	2,746,664	May 27 08:28 PM
Mackay Sean	SVP & Chief Business Officer	May 21 '25	Sale	1.03	12,838	13,223	868,829	May 23 06:13 PM
Mackay Sean	SVP & Chief Business Officer	May 22 '25	Sale	1.00	12,536	12,561	856,293	May 23 06:13 PM
Mackay Sean	Officer	May 23 '25	Proposed Sale	0.94	13,217	12,441		May 23 04:19 PM
Kim Hanjoon Alex	Officer	May 23 '25	Proposed Sale	0.94	1,428	1,344		May 23 04:18 PM
Egholm Michael	Officer	May 23 '25	Proposed Sale	0.94	5,473	5,152		May 23 04:09 PM
Egholm Michael	President & CEO	May 21 '25	Sale	1.03	4,719	4,861	2,751,780	May 22 08:03 PM
Kim Hanjoon Alex	Chief Financial Officer	May 21 '25	Sale	1.03	1,407	1,449	933,069	May 22 08:01 PM
Egholm Michael	Officer	May 22 '25	Proposed Sale	1.00	5,116	5,126		May 22 04:20 PM
Mackay Sean	Officer	May 22 '25	Proposed Sale	1.00	12,536	12,560		May 22 04:13 PM
Kim Hanjoon Alex	Officer	May 22 '25	Proposed Sale	1.00	1,355	1,358		May 22 04:07 PM
Kim Hanjoon Alex	Officer	May 21 '25	Proposed Sale	1.03	1,407	1,451		May 21 04:22 PM
Mackay Sean	Officer	May 21 '25	Proposed Sale	1.03	12,838	13,240		May 21 04:16 PM
Egholm Michael	Officer	May 21 '25	Proposed Sale	1.03	4,719	4,867		May 21 04:13 PM
Egholm Michael	President & CEO	Apr 04 '25	Option Exercise	0.00	196,512	0	2,832,518	Apr 08 04:04 PM
Kim Hanjoon Alex	Chief Financial Officer	Apr 04 '25	Option Exercise	0.00	70,183	0	962,281	Apr 08 04:03 PM
Casdin Partners Master Fund, L	Director	Feb 28 '25	Buy	1.06	4,820,959	5,134,321	58,846,780	Mar 04 08:19 PM
Black Jeffrey G.	Former Officer	Nov 12 '24	Proposed Sale	2.12	57,971	123,098		Nov 12 04:13 PM
Taich Adam	Former Officer	Sep 09 '24	Proposed Sale	2.00	45,851	91,725		Sep 09 03:19 PM
Casdin Partners Master Fund, L	Director	Aug 27 '24	Buy	2.19	250,000	546,750	54,025,821	Aug 29 08:30 PM
Casdin Partners Master Fund, L	Director	Aug 23 '24	Buy	2.13	292,100	620,975	53,625,821	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 22 '24	Buy	1.96	307,900	602,807	53,333,721	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 26 '24	Buy	2.15	150,000	322,455	53,775,821	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 21 '24	Buy	1.90	500,000	951,950	53,025,821	Aug 21 08:47 PM
Casdin Partners Master Fund, L	Director	Aug 20 '24	Buy	1.87	500,000	936,700	52,525,821	Aug 21 08:47 PM
Casdin Partners Master Fund, L	Director	Aug 19 '24	Buy	1.85	250,000	463,225	52,025,821	Aug 21 08:47 PM
Black Jeffrey G.	SVP & Chief Financial Officer	Aug 15 '24	Option Exercise	0.00	13,157	0	432,993	Aug 19 05:30 PM
Casdin Partners Master Fund, L	Director	Aug 14 '24	Buy	1.59	1,200,000	1,913,520	51,775,821	Aug 16 07:52 PM
Casdin Partners Master Fund, L	Director	Aug 13 '24	Buy	1.62	550,000	890,560	50,575,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 09 '24	Buy	1.61	525,408	848,481	49,525,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 12 '24	Buy	1.64	500,000	820,600	50,025,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 08 '24	Buy	1.64	569,562	932,601	49,000,413	Aug 09 09:34 PM
Casdin Partners Master Fund, L	Director	Aug 07 '24	Buy	1.57	500,000	786,200	48,430,821	Aug 09 09:34 PM
Casdin Partners Master Fund, L	Director	Aug 02 '24	Buy	1.63	1,000,000	1,631,900	47,730,821	Aug 06 09:58 PM
Casdin Partners Master Fund, L	Director	Aug 05 '24	Buy	1.58	200,000	316,780	47,930,821	Aug 06 09:58 PM

BLFS

Biolife Solutions Inc

LAB

Standard BioTools Inc

Upgrade your FINVIZ experience